Personal profile
Expertises
Lymphoma research with focus on DLBCL (NGS, pathology, DH lymphoma and treatment evaluation):Immunotherapy with focus on vaccination trial in MDS patient treated with azacytidine.
Main research areas
Lymphoma; NGS; pathology;
Immunotherapy; Myelodysplastic syndrome; vaccination
Current research
Several projects:
Peptide vaccination trial (Fase 1-2) in patients with MDS and treated with azacytidine. In the same project we investigate new epitopes in MDS patients. It is in cooperation with KVL/DTU.
NGS project in regard to DLBCL in cooperation with an international research group grounded at Duke University in Durham. Furthermore in this cooperation we are gathering data to do NGS in all hematologic malignancies.
Potential conflicts of interest
In regard to our peptide-vaccination trial in MDS we have an unrestricted grant from Celgene to purchase the peptides. I have received several travel grants to meetings abroad from different companies.
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
International Prognostic Models as Tools for Selection of Higher-risk Trial-eligible Patients With Diffuse Large B-Cell lymphoma
Jelicic, J., Juul-Jensen, K., Bukumiric, Z., Runason Simonsen, M., Roost Clausen, M., Ludvigsen Al-Mashhadi, A., Schou Pedersen, R., Poulsen, C. B., Gang, A. O., Brown, P., El-Galaly, T. C. & Stauffer Larsen, T., Jan 2026, In: Clinical Lymphoma, Myeloma & Leukemia. 26, 1, p. e62-e76Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
Validation of US Consensus Eligibility Criteria for Front-Line DLBCL Trials
Jelicic, J., Juul-Jensen, K., Bukumiric, Z., Rask Kragh Jørgensen, R., Runason Simonsen, M., Roost Clausen, M., Ludvigsen Al-Mashhadi, A., Schou Pedersen, R., Poulsen, C. B., Gang, A. O., Brown, P., El-Galaly, T. C. & Stauffer Larsen, T., Mar 2026, In: European Journal of Haematology. 116, 3, p. 290-301 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
A Real-World Data-Based Analysis of Prognostic Indices as Part of Trial Eligibility Criteria in Diffuse Large B-Cell Lymphoma Patients
Jelicic, J., Juul-Jensen, K., Bukumiric, Z., Runason Simonsen, M., Roost Clausen, M., Ludvigsen Al-Mashhadi, A., Schou Pedersen, R., Bjørn Poulsen, C., Ortved Gang, A., Brown, P., El-Galaly, T. C. & Stauffer Larsen, T., Jan 2025, In: European Journal of Haematology. 114, 1, p. 26-36 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
2 Citations (Scopus) -
Limited Benefit of Routine Clinical Follow-Up for Relapse Detection in Diffuse Large B-Cell Lymphoma Patients in Complete Remission Following First-Line Treatment
Lassen, T., Nielsen, T. H., von Heymann, A., Nielsen, L. K., Larsen, M. K., Gang, A. O., Johansen, C. & Pedersen, L. M., Mar 2025, In: American Journal of Hematology. 100, 3, p. 408-416 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
NOTCH1 Mutations Are Associated With Therapy-Resistance in Patients With B-Cell Lymphoma Treated With CD20xCD3 Bispecific Antibodies
Kyvsgaard, E. R., Grauslund, M., Sjø, L., Melchior, L. C., Grantzau, T. L., Gjerdrum, L. M. R., Trab, T., Andersen, L. S., Gang, A. O., Breinholt, M., Møller, M. B., Haaber Christensen, J., Larsen, T. S., Clausen, M. R., Riley, C. H., Niemann, C. U., Grønbæk, K., Hutchings, M. & Husby, S., Apr 2025, In: American Journal of Hematology. 100, 4, p. 712-716 5 p.Research output: Contribution to journal › Letter › peer-review
4 Citations (Scopus)